🇺🇸 FDA
Patent

US 7419967

Sulfonamide inhibitors of aspartyl protease

granted A61PA61P31/18

Quick answer

US patent 7419967 (Sulfonamide inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P31/18